Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EPIX | US
0.43
7.11%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
19/09/2024
6.48
6.36
6.76
6.11
ESSA Pharma Inc. a clinical stage pharmaceutical company focuses on developing novel and proprietary therapies for the treatment of prostate cancer. The company develops EPI-7386 an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. It has collaboration agreements with Caris Life Sciences Inc.; Bayer Consumer Care AG; Janssen Research & Development LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver Canada.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
111.9%1 month
82.5%3 months
73.7%6 months
73.9%-
-
2.36
0.00
0.00
-8.09
-
-
-23.50M
287.51M
287.51M
-
-
-
-
-19.83
32.75
3.87
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.61
Range1M
2.97
Range3M
3.63
Rel. volume
1.28
Price X volume
766.66K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Aurora Cannabis Inc | ACB | Drug Manufacturers-Specialty & Generic | 5.77 | 315.39M | -1.37% | n/a | 0.00% |
Solid Biosciences Inc | SLDB | Drug Manufacturers-Specialty & Generic | 8 | 308.76M | 12.04% | n/a | 13.09% |
Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 2.02 | 306.37M | 3.59% | n/a | -471.04% |
Cipher Pharmaceuticals Inc | CPHRF | Drug Manufacturers-Specialty & Generic | 11.03 | 284.72M | -3.50% | 12.74 | 0.00% |
Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 5.11 | 272.38M | 2.00% | n/a | 39.24% |
Procaps Group S.A. Ordinary Shares | PROC | Drug Manufacturers-Specialty & Generic | 1.8 | 203.08M | -0.55% | 3.63 | 0.00% |
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.84 | 176.87M | 4.80% | n/a | -113.78% |
LFCR | LFCR | Drug Manufacturers-Specialty & Generic | 5.62 | 173.65M | 8.08% | 20.72 | 241.85% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 2.25 | 157.36M | 2.27% | n/a | 1.07% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.13 | 129.73M | 1.96% | n/a | 1.10% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
MCBC Holdings Inc | MCFT | Recreational Vehicles | 18.35 | 304.85M | 2.23% | 35.51 | 26.82% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.5 | 236.20M | -2.49% | 9.50 | 39.79% |
Unifi Inc | UFI | Textile Manufacturing | 7.59 | 138.98M | 6.60% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 37.9 | 107.64M | -1.76% | 5.90 | 15.58% |
Culp Inc | CULP | Textile Manufacturing | 6.35 | 79.31M | 5.31% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 5.78 | 62.58M | -6.47% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.04 | 18.78M | 13.06% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 12.43M | -7.27% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.737 | 11.34M | 3.80% | n/a | 422.08% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6475 | 6.16M | -2.76% | n/a | 19.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -8.09 | 16.67 | Cheaper |
Ent. to Revenue | - | 309.37 | - |
PE Ratio | - | 29.14 | - |
Price to Book | 2.36 | 12.81 | Cheaper |
Dividend Yield | - | 2.80 | - |
Std. Deviation (3M) | 73.68 | 75.12 | Par |
Debt to Equity | 0.00 | -0.93 | Expensive |
Debt to Assets | 0.00 | 0.45 | Cheaper |
Market Cap | 287.51M | 5.22B | Emerging |